Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance
Clinical trial NCT07509424 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07509424
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-22
- Primary completion
- 2029-04-10
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.